Cytotoxic chemotherapy: clinical aspects

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

Medicine, Oncology, Pharmacology +15

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

Rolf Sauer, Heinz Becker, Werner Hohenberger et al. · New England Journal of Medicine · 2004 · 6.1K citations

Medicine, Oncology, Surgery +10

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations

Medicine, Oncology, Pharmacology +9

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian, Gary H. Lyman et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Giuseppe Colucci, Vittorio Gebbia, G Paoletti et al. · Journal of Clinical Oncology · 2005 · 781 citations

Medicine, Oncology, Pharmacotherapy +11